Quest Diagnostics Incorporated

NYSE-DGX

Overview Financials Investor Relations Estimates Ownership Industry Dividends Modeling Filings

Income Statement	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23	LTM
Total Revenues						7,726	9,437	10,788	9,883	9,252	9,346
Total Revenues % Chg.						2.6%	22.1%	14.3%	-8.4%	-6.4%	-1.5%
Cost of Goods Sold, Total						5,037	5,795	6,571	6,418	6,183	6,261
Gross Profit						2,689	3,642	4,217	3,465	3,069	3,085
Selling General & Admin Expenses, Total						1,457	1,545	1,723	1,818	1,615	1,624
Amortization of Goodwill and Intangible Assets						96	103	103	120	108	112
Other Operating Expenses	—	—				-16	6	-2	-22	12	11
Other Operating Expenses, Total						1,537	1,654	1,824	1,916	1,735	1,747
Operating Income						1,152	1,988	2,393	1,549	1,334	1,338
Interest Expense, Total						-180	-166	-152	-148	-163	-183
Interest And Investment Income						5	3	1	10	11	16
Net Interest Expenses						-175	-163	-151	-138	-152	-167
Income (Loss) On Equity Invest.						57	75	78	44	26	22
Other Non Operating Income (Expenses)						20	76	55	-25	20	19
EBT, Excl. Unusual Items						1,054	1,976	2,375	1,430	1,228	1,212
Restructuring Charges						—	-14	-12	-102	-72	-73
Merger & Related Restructuring Charges				—	—	—	—	—	—	—	—
Gain (Loss) On Sale Of Investments	—	—			—	—	—	314	-30	—	—
Gain (Loss) On Sale Of Assets	—			—		73	-3	—	—	—	—
Asset Writedown	—			—	—	—	—	—	-14	—	—
Other Unusual Items				—		6	—	—	-5	—	-1
EBT, Incl. Unusual Items						1,133	1,959	2,677	1,279	1,156	1,138
Income Tax Expense						247	460	597	264	248	248
Earnings From Continuing Operations						886	1,499	2,080	1,015	908	890
Earnings Of Discontinued Operations		—	—	—	—	20	—	—	—	—	—
Minority Interest						-48	-68	-85	-69	-54	-50
Net Income						858	1,431	1,995	946	854	840
Preferred Dividend and Other Adjustments						3	6	7	4	4	4
Net Income to Common Incl Extra Items						855	1,425	1,988	942	850	836
Net Income to Common Excl. Extra Items						835	1,425	1,988	942	850	836
Total Shares Outstanding						133	133	119	111	111	111
Weighted Avg. Shares Outstanding						134	134	125	116	112	111.5
Weighted Avg. Shares Outstanding Dil						136	136	128	118	113	112
EPS						6.4	10.6	15.9	8.1	7.6	7.5
EPS Diluted						6.3	10.5	15.6	8	7.5	7.4
EBITDA						1,481	2,349	2,801	1,986	1,773	1,791
Effective Tax Rate						21.8%	23.5%	22.3%	20.6%	21.5%	21.8%